NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of Global Infectious Disease Surveillance and Detection

Global Infectious Disease Surveillance and Detection

Assessing the Challenges—Finding Solutions, Workshop Summary


Washington (DC): National Academies Press (US); .
ISBN-13: 978-0-309-11114-0ISBN-10: 0-309-11114-5

Early detection is essential to the control of emerging, reemerging, and novel infectious diseases, whether naturally occurring or intentionally introduced. Containing the spread of such diseases in a profoundly interconnected world requires active vigilance for signs of an outbreak, rapid recognition of its presence, and diagnosis of its microbial cause, in addition to strategies and resources for an appropriate and efficient response. Although these actions are often viewed in terms of human public health, they also challenge the plant and animal health communities. The Forum on Microbial Threats of the Institute of Medicine hosted a public workshop in Washington, DC, on December 12 and 13, 2006, to consider the scientific and policy issues—some of them long standing, others more recently arisen—relevant to the practice of disease surveillance and detection. Through invited presentations and discussions, participants examined current and emerging methods and strategies for the surveillance and detection of human, animal, and plant diseases, and assessed the resource needs and opportunities for improving and coordinating infectious disease surveillance, detection, and reporting.


Rapporteurs: Stanley M Lemon, Margaret A Hamburg, P Frederick Sparling, Eileen R Choffnes, and Alison Mack

This project was supported by contracts between the National Academy of Sciences and the U.S. Department of Health and Human Services: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Centers for Disease Control and Prevention, and Food and Drug Administration; U.S. Department of Defense: Global Emerging Infections Surveillance and Response System, Walter Reed Army Institute of Research, and Defense Threat Reduction Agency; U.S. Department of Veterans Affairs; U.S. Department of Homeland Security; Lawrence Livermore National Laboratory; American Society for Microbiology; Sanofi Pasteur; Burroughs Wellcome Fund; Pfizer; GlaxoSmithKline; Infectious Diseases Society of America; and the Merck Company Foundation.

Suggested citation:

Institute of Medicine. 2007. Global infectious disease surveillance and detection: Assessing the challenges—finding solutions. Workshop summary. Washington, DC: The National Academies Press.

Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project.

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.

Copyright © 2007, National Academy of Sciences.
Bookshelf ID: NBK52867PMID: 21391348DOI: 10.17226/11996


  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (9.2M)

Related information

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...